MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'blood thinners'. Sat, 03 Sep 2011 02:38:11 +0100 http://www.medworm.com/index.php?rid=5077690&cid=t_133128_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fthe-best-time-to-be-treated-for-a-dvt%2F2011.07.28 You know I am a cancer survivor – 15 years down the road from a leukemia diagnosis and enjoying a 10 year remission. So whenever something seems weird about my health it’s cancer coming back, right? Wrong! Just how wrong was proven last night. I am writing this from my hospital bed in Seattle. The first symptom of a possible problem came three days ago when I had soreness in my right calf. A pulled muscle? Maybe. But I had not noticed straining it. Back at the gym the next day I had soreness again but thought it was no big deal. Last night it was worse. It hurt some to walk. I got home and, after my wife and son were asleep, got ready for bed. I had a slight fever and then noticed the right calf was not only sore, but swollen and warm. Very strange. I’d never seen that before. Trying... Better Health blogs http://www.medworm.com/rss/comments.php?id=5077690 Thu, 28 Jul 2011 18:00:02 +0100 5077690 http://www.medworm.com/index.php?rid=5062245&cid=t_133128_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fnew-blood-thinner-shifts-responsibility-to-patients%2F2011.07.24 I recently came across a very important blog post on the use of the novel new blood-thinner, dabigatran (Pradaxa). Fellow Kentucky cardiologist, and frequent TheHeart.org contributor, Dr. Melissa Walton-Shirley wrote this very detailed case presentation involving a cantankerous non-compliant rural patient with AF (atrial fibrillation) that sustained a stroke while “taking” dabigatran. Dr. Walton-Shirley details the very commonly done procedure of cardioversion (shock) for AF. As she clearly points out, the most important safety feature of shocking AF back to regular rhythm entails adequate blood thinning before and after the procedure. Thin blood prevents the possibility of clots dislodging after restoring normal contraction to the top chambers of the heart (atria). Herein lies the rub... Better Health blogs http://www.medworm.com/rss/comments.php?id=5062245 Sun, 24 Jul 2011 18:00:37 +0100 5062245 http://www.medworm.com/index.php?rid=4294629&cid=t_133128_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fthe-business-of-anticoagulation%2F2010.12.28 This is a guest post by Dr. Juliet Mavromatis: ********** The emergence of a new generation of anticoagulants, including the direct thrombin inhibitor, dabigatran and the factor Xa inhibitor, rivaroxaban, has the potential to significantly change the business of thinning blood in the United States. For years warfarin has been the main therapeutic option for patients with health conditions such as atrial fibrillation, venous thrombosis, artificial heart valves and pulmonary embolus, which are associated with excess clotting risk that may cause adverse outcomes, including stroke and death. However, warfarin therapy is fraught with risk and liability. The drug interacts with food and many drugs and requires careful monitoring of the prothrombin time (PT) and international normalized ratio (IN... Better Health blogs http://www.medworm.com/rss/comments.php?id=4294629 Tue, 28 Dec 2010 15:00:00 +0100 4294629 http://www.medworm.com/index.php?rid=3921076&cid=t_133128_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F94A_3qfmuDs%2F The battle to prevent blood clots is heating up this week as several drugmakers begin releasing study results for their experimental drugs. At stake, of course, is a huge market for stroke prevention that is worth billions of dollars, since the new meds are designed to supplant warfarin and aspirin, which are troublesome or simply less effective. Toward that end, Bristol-Myers Squibb and Pfizer issued results showing patients taking their apixaban blood thinner were 54 percent less likely to have a stroke or damaging clot than those taking aspirin, and did not show significant signs of bleeding. Their Averroes study, which was presented at the European Society of Cardiology conference in Stockholm, involved about 5,600 people suffering atrial fibrillation and who are unable to use warfarin... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3921076 Tue, 31 Aug 2010 12:05:34 +0100 3921076 http://www.medworm.com/index.php?rid=3784497&cid=t_133128_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6HqJvyNr744%2F After five-plus years of anticipation, the FDA has approved a generic version of Lovenox, a $4 billion blood thinner sold by Sanofi-Aventis. The approval comes after a three-way race between Momenta Pharmaceutical, which received the agency endorsement, and two others - Amphastar Pharmaceuticals and Teva Pharmaceutical. There is no word on approval for the rival meds (here is the FDA statement). In a word, this is really about biologics and the implications are enormous. “Lovenox is technically not a biologic, yet functionally and effectively it is,” writes Sanford Bernstein analyst Tim Anderson in an investor note. “Many in industry have felt that if FDA ultimately approves generic versions of Lovenox and it makes those generics fully substitutable - which it just has - ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3784497 Fri, 23 Jul 2010 20:53:22 +0100 3784497 http://www.medworm.com/index.php?rid=3089363&cid=t_133128_109_f&fid=35671&url=http%3A%2F%2Fwww.anxietyinsights.info%2Fssris_linked_to_upper_gastrointestinal_bleeding.htm (HealthDay News)by — Eric Metcalf MONDAY, Dec. 14 (HealthDay News) — Selective serotonin reuptake inhibitors (SSRIs) are associated with an increased risk of upper gastrointestinal bleeding, which warrants caution when prescribing these drugs in patients at elevated risk for this type of bleeding, according to research published in the December issue of Clinical Gastroenterology and Hepatology. More... Copyright © 2009 ScoutNews, LLC. All rights reserved. (Source: Latest entries from www.anxietyinsights.info) Latest entries from www.anxietyinsights.info blogs http://www.medworm.com/rss/comments.php?id=3089363 Tue, 15 Dec 2009 07:16:00 +0100 3089363 http://www.medworm.com/index.php?rid=1886687&cid=t_133128_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F422722216%2F Several drug and device makers are participating in a $100 million, 20,000-patient study to figure out how to protect heart patients from blood clots after being treated with stents, The Wall Street Journal reports. At issue is whether patients can safely stop using blood thinners one year after a procedure or if they should take such a med for at least two and a half years. Current guidelines call for patients who get a drug-coated stent to remain on the med for at least a year. But concern that, in rare instances, clots can form in the devices well over a year after they are implanted, with potentially lethal consequences, has left doctors and patients in a quandary over how long treatment should be prescribed, the Journal writes. “It’s created a lot of anxiety in patients&#8... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1886687 Thu, 16 Oct 2008 14:44:20 +0100 1886687 http://www.medworm.com/index.php?rid=1779653&cid=t_133128_109_f&fid=35671&url=http%3A%2F%2Fwww.anxietyinsights.info%2Fthe_blood_curdling_effects_of_severe_anxiety.htm Study shows that people with anxiety disorders tend to suffer from increased blood clottingThe blood froze in my veins" or "My blood curdled" - these common figures of speech can be taken literally, according to the latest studies. Indeed, more literally than some of us would like. For it turns out that intense fear and panic attacks can really make our blood clot and increase the risk of thrombosis or heart attack. Earlier studies showed that stress and anxiety can influence coagulation. However, they were based almost entirely on questionnaire surveys of healthy subjects. In contrast, the Bonn-based research team lead by Franziska Geiser and Ursula Harbrecht an examination of coagulation in patients with anxiety disorders. Everyone experiences anxiety from time to time - fear of failing ... Latest entries from www.anxietyinsights.info blogs http://www.medworm.com/rss/comments.php?id=1779653 Wed, 10 Sep 2008 09:11:00 +0100 1779653 http://www.medworm.com/index.php?rid=1223814&cid=t_133128_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F233370932%2F That’s the interpretation from Tim Anderson, a securities analyst at Sanford Bernstein, who notes that the drugmaker hasn’t crowed about receiving a 6-month priority review, even though last Friday was the date by which the agency would have conveyed its decision. In an investor note today, Anderson writes that Lilly filed its request on Dec. 26 and, as a result, the blood thinner will likely receive the standard 10-month review instead. ” To us it increasingly looks like the product may not get a 6-month “priority review” by FDA,” writes Anderson. “The date by which Lilly would have likely learned of FDA’s decision appears to have been around last Friday. While an ‘official’ letter may not go out to Lilly until sometime later, ou... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1223814 Mon, 11 Feb 2008 21:25:19 +0100 1223814 http://www.medworm.com/index.php?rid=1002550&cid=t_133128_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F179591717%2F The drugmaker has just released the news that many have been anticipating - its prasugrel blood thinner can lower the risk of cardiovascular death, non-fatal heart attacks or non-fatal strokes when compared with Plavix. But its Triton study also found that the med caused some patients to experience a statistically significant increase in major bleeding compared to those treated with Plavix, the $7 billion gorilla of blood thinners. Overall, for every 1,000 people treated with prasugrel compared to clopidogrel in the study, there were 23 fewer heart attacks and an additional six major bleeding complications. John Alexander, who heads global research and development at Daiichi Sankyo, Lilly’s prasugrel partner, says that “given the promising results, (the companies) are expeditio... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1002550 Sun, 04 Nov 2007 13:47:44 +0100 1002550 http://www.medworm.com/index.php?rid=745514&cid=t_133128_87_f&fid=34866&url=http%3A%2F%2Fwww.thecardioblog.com%2F2007%2F07%2F20%2Fprescribed-a-blood-thinner-things-you-should-know%2F Filed under: Prevention, DrugsShortly after giving birth to her first child, my sister-in-law developed a blood clot that traveled to her lung. Because she's only in her mid-30s, she was surprised to find out she'd be taking blood thinners for the rest of her life, due to a previously undiscovered genetic blood clotting disorder. Though blood thinners are commonly prescribed to those with high risk of heart attack or stroke, they're also prescribed to prevent blood clots and to those who suffer from atrial fibrillation and congestive heart failure. When you first start using blood thinners, there are a few basics you should know, including: Blood thinners may interact with other medications you are taking, so be sure to tell you doctor about all prescription and over-the-counter drugs y... The Cardio Blog blogs http://www.medworm.com/rss/comments.php?id=745514 Fri, 20 Jul 2007 04:00:00 +0100 745514